Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20+ B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL.
M. Pfreundschuh
No relevant relationships to disclose
M. Ziepert
No relevant relationships to disclose
S. Zeynalova
No relevant relationships to disclose
E. Lengfelder
No relevant relationships to disclose
H. Steinhauer
No relevant relationships to disclose
M. R. Clemens
No relevant relationships to disclose
C. Nickenig
No relevant relationships to disclose
A. D. Ho
No relevant relationships to disclose
L. H. Truemper
No relevant relationships to disclose
M. Hoffmann
No relevant relationships to disclose
R. H. Mertelsmann
No relevant relationships to disclose
B. Metzner
No relevant relationships to disclose
H. Mergenthaler
No relevant relationships to disclose
V. Poeschel
No relevant relationships to disclose
N. Schmitz
No relevant relationships to disclose
M. Loeffler
No relevant relationships to disclose